Open AccessJournal Article
lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
TLDR
It is found that overexpression of lncRNA MEG3 could decrease the proliferation and metastasis of gastric cancer cells and could also increase the expression of p53.Abstract:
Objective lncRNA MEG3 has been reported as a tumor suppressor gene in many different kinds of cancer, but its role in gastric cancer has not been fully understood. Then, we would like to explore its mechanism in gastric cancer. Patients and methods We first used qRT-PCR to detect the expression of lncRNA MEG3, then CCK8 and wound healing assay were used to detect the effect of lncRNA MEG3 on gastric cancer cells. Western blot assay was used to measure the expression of p53 when lncRNA MEG3 was overexpressed. Results lncRNA MEG3 was highly expressed in the adjacent tissue, compared to the one in gastric cancer tissue. What's more, we also found that overexpression of lncRNA MEG3 could decrease the proliferation and metastasis of gastric cancer cells. Finally, overexpression of lncRNA MEG3 could also increase the expression of p53. Conclusions lncRNA MEG3 could inhibit the proliferation and metastasis of gastric cancer.read more
Citations
More filters
Journal ArticleDOI
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
Elena A. Pudova,George S. Krasnov,Anastasiya A. Kobelyatskaya,Maria V Savvateeva,Maria S. Fedorova,Vladislav S Pavlov,Kirill M. Nyushko,Andrey Kaprin,Boris Alekseev,Dmitry Yu. Trofimov,Gennady T. Sukhikh,Anastasiya V. Snezhkina,Anna V. Kudryavtseva +12 more
TL;DR: In this paper, a bioinformatic analysis of The Cancer Genome Atlas (TCGA) datasets, including RNA-Seq data from the prostate adenocarcinoma (PRAD), and West Coast Dream Team - metastatic CRPC (WCDT-MCRPC), was performed, to evaluate the transcriptome changes associated with progression-free survival (PFS) for LAPC and CRPC, respectively.
Journal ArticleDOI
Identification of key long non-coding RNAs in gastric adenocarcinoma.
TL;DR: This study identifies key lncRNAs in gastric adenocarcinoma which provides clues for exploring the pathogenesis and developing potential biomarkers for gastricAdenocARCinoma.
Journal ArticleDOI
A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets.
TL;DR: In this paper, a risk score model based on the expression of five long non-coding RNAs (lncRNAs) was proposed to predict the prognosis of patients with Gastric cancer.
Journal ArticleDOI
TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer
Wenting He,Dachuan Zhang,Xiaodong Li,Jun Wu,Xuanxuan Yang,Qi Wang,Wenbin Lu,Jingting Jiang,Changping Wu +8 more
TL;DR: The results of the present study provide information on the role of the ceRNA network in GC and identify novel lncRNAs that are potential candidate biomarkers and require further studies.
Journal ArticleDOI
LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non‐small cell lung cancer
TL;DR: In this article, the effects of HOXA transcript antisense RNA, myeloid-specific 1 (HOTAIRM1) and microRNA-498 (miR-498) on NSCLC progression and underlying mechanism were revealed.